Pfizer in talks on $5 billion acquisition: media

American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.

source https://medicalxpress.com/news/2022-08-pfizer-billion-acquisition-media.html